Page last updated: 2024-09-04

wilforlide a and bicalutamide

wilforlide a has been researched along with bicalutamide in 1 studies

*bicalutamide: approved for treatment of advanced prostate cancer [MeSH]

*bicalutamide: approved for treatment of advanced prostate cancer [MeSH]

Compound Research Comparison

Studies
(wilforlide a)
Trials
(wilforlide a)
Recent Studies (post-2010)
(wilforlide a)
Studies
(bicalutamide)
Trials
(bicalutamide)
Recent Studies (post-2010) (bicalutamide)
13061,313212541

Protein Interaction Comparison

ProteinTaxonomywilforlide a (IC50)bicalutamide (IC50)
Progesterone receptorOryctolagus cuniculus (rabbit)5.6
Progesterone receptorHomo sapiens (human)1.819
Androgen receptorHomo sapiens (human)0.404
Androgen receptorRattus norvegicus (Norway rat)0.7168
Androgen receptorMus musculus (house mouse)1.835
Testosterone 17-beta-dehydrogenase 3Homo sapiens (human)0.12
Progesterone receptorRattus norvegicus (Norway rat)0.89

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cen, S; He, Y; Hu, L; Li, Q; Li, X; Liu, Y; Wu, M; Zhou, J1

Other Studies

1 other study(ies) available for wilforlide a and bicalutamide

ArticleYear
Identification of Triptophenolide from
    ACS medicinal chemistry letters, 2016, Dec-08, Volume: 7, Issue:12

    Topics:

2016